Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Acta Psychiatr Scand ; 113(2): 82-90, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16423158

RESUMEN

OBJECTIVE: Schizophrenia affects roughly 1% of the population and is considered one of the top 10 causes of disability worldwide. Given the immense cost to society, successful treatment options are imperative. Based on initial findings, gluten withdrawal may serve as a safe and economical alternative for the reduction of symptoms in a subset of patients. METHOD: A review of the literature relevant to the association between schizophrenia and celiac disease (gluten intolerance) was conducted. RESULTS: A drastic reduction, if not full remission, of schizophrenic symptoms after initiation of gluten withdrawal has been noted in a variety of studies. However, this occurs only in a subset of schizophrenic patients. CONCLUSION: Large-scale epidemiological studies and clinical trials are needed to confirm the association between gluten and schizophrenia, and address the underlying mechanisms by which this association occurs.


Asunto(s)
Enfermedad Celíaca/epidemiología , Glútenes/efectos adversos , Esquizofrenia/epidemiología , Enfermedades Autoinmunes/dietoterapia , Enfermedades Autoinmunes/epidemiología , Enfermedades Autoinmunes/genética , Enfermedades Autoinmunes/inmunología , Enfermedad Celíaca/dietoterapia , Enfermedad Celíaca/genética , Enfermedad Celíaca/inmunología , Enfermedad Crónica , Citocinas/sangre , Predisposición Genética a la Enfermedad/genética , Glútenes/administración & dosificación , Glútenes/inmunología , Humanos , Inmunidad Celular/inmunología , Factores de Riesgo , Esquizofrenia/dietoterapia , Esquizofrenia/genética , Esquizofrenia/inmunología , Estadística como Asunto
2.
Life Sci ; 64(6-7): 375-9, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10069499

RESUMEN

We have investigated the molecular mechanisms involved in the regulation of muscarinic acetylcholine receptor gene expression and localization and generated knockout mice to study the role of the M1 muscarinic receptor in vivo. We have used the MDCK cell system to demonstrate that different subtypes of mAChR can be targeted to different regions of polarized cells. We have also examined the developmental regulation of mAChR expression in the chick retina. Early in development, the M4 receptor is the predominant mAChR while the levels of the M2 and M3 receptors increase later in development. The level of M2 receptor is also initially very low in retinal cultures and undergoes a dramatic increase over several days in vitro. The level of M2 receptor can be increased by a potentially novel, developmentally regulated, secreted factor produced by retinal cells. The promoter for the chick M2 receptor gene has been isolated and shown to contain a site for GATA-family transcription factors which is required for high level cardiac expression. The M2 promoter also contains sites which mediate induction of transcription in neural cells by neurally active cytokines. We have generated knockout mice lacking the M1 receptor and shown that these mice do not exhibit pilocarpine-induced seizures and muscarinic agonist-induced suppression of the M-current potassium channel in sympathetic neurons.


Asunto(s)
Regulación del Desarrollo de la Expresión Génica , Receptores Muscarínicos/genética , Animales , Embrión de Pollo , Ratones , Ratones Noqueados , Regiones Promotoras Genéticas/genética , Receptores Muscarínicos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...